BANK OF MONTREAL /CAN/ - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2020$16,000
-11.1%
22,8000.0%0.00%
Q3 2020$18,000
-93.4%
22,800
-81.2%
0.00%
Q4 2018$274,000
+42.7%
121,400
+121.5%
0.00%
Q3 2018$192,000
-73.6%
54,800
-75.9%
0.00%
Q2 2018$728,000227,6000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders